Insilicos appoints Teresa Skarr as Director of Regulatory Affairs

Seattle, 8 July 2005 - Seattle biotech company Insilicos today announced that Teresa Skarr has joined the company as Director of Regulatory Affairs. Skarr will lead Insilicos' quality and regulatory approval efforts.
Skarr has 15 years experience in regulatory affairs and clinical program management. Her extensive biomedicine background of over 15 years includes regulatory posts at Philips Medical Systems; Heartstream; Sanofi Diagnostics Pasteur; and Becton, Dickinson. Skarr's experience also includes quality and clinical trial design.
"We're pleased to have Teresa as part of our team," said Insilicos President Erik Nilsson. "Her knowledge and experience will be great assets as we apply our technology to clinical diagnostics."

Insilicos LLC is a biomarker discovery and diagnostic development company, concentrating on cardiovascular disease.

For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' 'PreClue," and 'Life Science Software' are trademarks of Insilicos LLC.